The plaintiff's claim is dismissed.

Litigation costs shall be borne by the plaintiff.

. : It shall be diagnosed as chronic closed diseases in light of the degree of difficulty in normal pulmonary and the results of pulmonary function tests;

It is necessary to observe the continuous treatment and tracking of drugs in the future, and it may be necessary to treat hospitalized in the event of aggravation of the condition.

The results of the first inspection (FEV1/FV*100) and the second inspection (FEV1/10, July 11, 2017) were similar, and the higher results were derived from 1 second rate (FEV1/FV*100) and 85 percent (FE1).

C) On July 11, 2017, at the Defendant’s advice, the 1st century’s response (FV1) is more than 85% of a normal forecast, and does not meet the standards for diagnosis of chronic closed-end diseases. The examination of the volume of waste is considered to be a result of trust. (d) The Plaintiff’s self-defluence symptoms of this Court (FV1), as a result of the physical examination entrustment (FV1) of this Court, include the Plaintiff’s self-defluence symptoms, such as invasion, guest voice, obssis, chest response, chronic disorder, chronic disorder, pathy disorder, and chronology.

There was no special opinion in the simple chest X-ray photograph, and there was 98% of compulsory pulmonary active (FVC), 11 (FE1) 78%, and 111 (FEV1/FC*100) 66%.The degree of injury of the plaintiff is serious (GOLD2) when based on international programs on chronic closed-pulmonary diseases (COPD).

The treatment shall not be completed as it is difficult to completely recover from a pulmonary and chronic closed disease, and it shall be treated in a life.

Treatment of COPD is different depending on the patient's symptoms and conditions of illness, and it is different depending on risk and aggravation.

COPD may scalculous aggravation by many factors, such as infection, scarcity, and medicine. D) The result of the court’s physical appraisal commission (i.e., pulmonary exposure, pulmonary exposure, and calcule exa) was conducted only on July 7, 2020, and the remaining two public prosecutors are not essential to the diagnosis of chronic pulmonary diseases. The diagnosis of chronic pulmonary diseases is conducted by the pulmonary exposure testing, and the diagnosis of health dilution is conducted by the diagnosis of chronic pulmonary diseases, but the diagnosis of patients shows the gravity of chronic pulmonary diseases.